CORY WILES: Open Payments
NPI 1982017661 · LENOIR, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,960 in 53 payments from 18 companies in 2025. Trend: 2023 $440 · 2024 $823 · 2025 $1,960
Food & beverage: $1,123Travel & lodging: $818Education: $19
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 21 | $1,362 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Amgen Inc. | 5 | $77 |
| Boston Scientific Corporation | 2 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| CVRx, Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
Products named: SAPIEN 3 Ultra RESILIA, Repatha, ELIQUIS, Kerendia, LEQVIO, General - Therapies, FUROSCIX, WAINUA.
Industry payments across NC — which companies pay providers there.
